Hideya Kawaji

Find an error

Name:
Organization: Riken , Japan
Department:
Title: (PhD)
Co-reporter:Masahito Yoshihara, Susumu Hara, Motokazu Tsujikawa, Satoshi Kawasaki, ... Kohji Nishida
EBioMedicine 2017 Volume 25(Volume 25) pp:
Publication Date(Web):1 November 2017
DOI:10.1016/j.ebiom.2017.10.024
•We comprehensively profiled promoter-level expression of human corneal endothelial cells.•Integrative transcriptome analysis identified 28 corneal endothelial cell-specific marker genes.•POU6F2 expression is restricted to corneal endothelial cells, and upregulated during differentiation.Corneal endothelial cells (CECs) are essential for maintaining corneal transparency. Owing to the high prevalence of corneal endothelial disorders, CECs are important targets in regenerative medicine. However, it has been difficult to evaluate the final CEC products owing to the lack of appropriate CEC-specific markers. In this study, we identified 28 CEC-specific marker genes by integrative transcriptome analysis. One gene of particular interest, POU6F2, is expressed almost exclusively in CECs, and upregulated during differentiation. These markers would be useful for the assessment of CECs derived from pluripotent stem cells, and this study will facilitate the translation of corneal regenerative medicine.Corneal endothelial cells (CECs) are essential for maintaining the clarity of the cornea. Because CECs have limited proliferative ability, interest is growing in their potentially therapeutic regeneration from pluripotent stem cells. However, the molecular mechanisms of human CEC differentiation remain largely unknown. To determine the key regulators of CEC characteristics, here we generated a comprehensive promoter-level expression profile of human CECs, using cap analysis of gene expression (CAGE) with a single molecule sequencer. Integration with the FANTOM5 promoter-level expression atlas, which includes transcriptome profiles of various human tissues and cells, enabled us to identify 45 promoters at 28 gene loci that are specifically expressed in CECs. We further discovered that the expression of transcription factor POU class 6 homeobox 2 (POU6F2) is restricted to CECs, and upregulated during human CEC differentiation, suggesting that POU6F2 is pivotal to terminal differentiation of CECs. These CEC-specific promoters would be useful for the assessment of fully differentiated CECs derived from pluripotent stem cells. These findings promote the development of corneal regenerative medicine.
Co-reporter:Margaret R. Davis, Robin Andersson, Jessica Severin, Michiel de Hoon, ... Kim M. Summers
Molecular Genetics and Metabolism (May 2014) Volume 112(Issue 1) pp:73-83
Publication Date(Web):1 May 2014
DOI:10.1016/j.ymgme.2013.12.006
•We examine expression, promoter use and enhancers for the fibrillin/LTBP gene family.•Promoter switching was observed for most family members.•Multiple enhancers were identified for all family members.•Family members overlapped in tissue specificity with some unique expression patterns.•A degree of redundancy among family members is possible.The fibrillins and latent transforming growth factor binding proteins (LTBPs) form a superfamily of extracellular matrix (ECM) proteins characterized by the presence of a unique domain, the 8-cysteine transforming growth factor beta (TGFβ) binding domain. These proteins are involved in the structure of the extracellular matrix and controlling the bioavailability of TGFβ family members. Genes encoding these proteins show differential expression in mesenchymal cell types which synthesize the extracellular matrix. We have investigated the promoter regions of the seven gene family members using the FANTOM5 CAGE database for human. While the protein and nucleotide sequences show considerable sequence similarity, the promoter regions were quite diverse. Most genes had a single predominant transcription start site region but LTBP1 and LTBP4 had two regions initiating different transcripts. Most of the family members were expressed in a range of mesenchymal and other cell types, often associated with use of alternative promoters or transcription start sites within a promoter in different cell types. FBN3 was the lowest expressed gene, and was found only in embryonic and fetal tissues. The different promoters for one gene were more similar to each other in expression than to promoters of the other family members. Notably expression of all 22 LTBP2 promoters was tightly correlated and quite distinct from all other family members. We located candidate enhancer regions likely to be involved in expression of the genes. Each gene was associated with a unique subset of transcription factors across multiple promoters although several motifs including MAZ, SP1, GTF2I and KLF4 showed overrepresentation across the gene family. FBN1 and FBN2, which had similar expression patterns, were regulated by different transcription factors. This study highlights the role of alternative transcription start sites in regulating the tissue specificity of closely related genes and suggests that this important class of extracellular matrix proteins is subject to subtle regulatory variations that explain the differential roles of members of this gene family.
Somatostatin
Calcium, compd. with germanium (1:1)
IRON;VANADIUM
brain natriuretic peptide-32 human
Interleukin 4 (human) (9CI)